678 related articles for article (PubMed ID: 7502042)
1. Fas ligand-induced apoptosis as a mechanism of immune privilege.
Griffith TS; Brunner T; Fletcher SM; Green DR; Ferguson TA
Science; 1995 Nov; 270(5239):1189-92. PubMed ID: 7502042
[TBL] [Abstract][Full Text] [Related]
2. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Fas ligand-induced apoptosis by TNF.
Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and increased expression of Fas ligand after uniocular anterior chamber (AC) inoculation of HSV-1.
Qian H; Atherton S
Curr Eye Res; 2003; 26(3-4):195-203. PubMed ID: 12815547
[TBL] [Abstract][Full Text] [Related]
5. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French LE; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
Science; 1996 Nov; 274(5291):1363-6. PubMed ID: 8910274
[TBL] [Abstract][Full Text] [Related]
6. Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
Nguyen QD; Uy HS; Merchant A; Medina CA; Baltatzis S; Zhao T; Zhao ZS; Cantor H; Foster CS
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2505-9. PubMed ID: 11581190
[TBL] [Abstract][Full Text] [Related]
7. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
Kawashima H; Yamagami S; Tsuru T; Gregerson DS
Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
[TBL] [Abstract][Full Text] [Related]
8. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance.
Griffith TS; Yu X; Herndon JM; Green DR; Ferguson TA
Immunity; 1996 Jul; 5(1):7-16. PubMed ID: 8758890
[TBL] [Abstract][Full Text] [Related]
9. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
10. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
Fecho K; Cohen PL
J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
[TBL] [Abstract][Full Text] [Related]
11. Immune privilege or inflammation? The paradoxical effects of Fas ligand.
O'Connell J
Arch Immunol Ther Exp (Warsz); 2000; 48(2):73-9. PubMed ID: 10807046
[TBL] [Abstract][Full Text] [Related]
12. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion.
Uckan D; Steele A; Cherry ; Wang BY; Chamizo W; Koutsonikolis A; Gilbert-Barness E; Good RA
Mol Hum Reprod; 1997 Aug; 3(8):655-62. PubMed ID: 9294848
[TBL] [Abstract][Full Text] [Related]
13. A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege.
Gregory MS; Koh S; Huang E; Saff RR; Marshak-Rothstein A; Mukai S; Ksander BR
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2495-502. PubMed ID: 15980241
[TBL] [Abstract][Full Text] [Related]
14. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.
Maher S; Toomey D; Condron C; Bouchier-Hayes D
Immunol Cell Biol; 2002 Apr; 80(2):131-7. PubMed ID: 11940113
[TBL] [Abstract][Full Text] [Related]
15. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
French LE; Hahne M; Viard I; Radlgruber G; Zanone R; Becker K; Müller C; Tschopp J
J Cell Biol; 1996 Apr; 133(2):335-43. PubMed ID: 8609166
[TBL] [Abstract][Full Text] [Related]
16. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart PM; Griffith TS; Usui N; Pepose J; Yu X; Ferguson TA
J Clin Invest; 1997 Feb; 99(3):396-402. PubMed ID: 9022072
[TBL] [Abstract][Full Text] [Related]
17. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis.
Gao Y; Herndon JM; Zhang H; Griffith TS; Ferguson TA
J Exp Med; 1998 Sep; 188(5):887-96. PubMed ID: 9730890
[TBL] [Abstract][Full Text] [Related]
18. The Fas system in the seminiferous epithelium and its possible extra-testicular role.
Riccioli A; Salvati L; D'Alessio A; Starace D; Giampietri C; De Cesaris P; Filippini A; Ziparo E
Andrologia; 2003 Feb; 35(1):64-70. PubMed ID: 12558530
[TBL] [Abstract][Full Text] [Related]
19. Expression of Fas-Fas ligand system associated with atresia in murine ovary.
Xu JP; Li X; Mori E; Sato E; Saito S; Guo MW; Mori T
Zygote; 1997 Nov; 5(4):321-7. PubMed ID: 9563680
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
